Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

Presentation TCT 2017

Case #6 (With Discussion): STEMI and an Intact Fibrous Cap

Presenter: Henning Kelbæk, Renu Virmani, Ik-Kyung Jang

November 01, 2017

Presentation TCT 2017

Case #5 (With Discussion): Spontaneous Coronary Artery Dissection

Presenter: Henning Kelbæk, Renu Virmani, Adriano Caixeta

November 01, 2017

Presentation TCT 2017

Case #4 (With Discussion): A Patient With STEMI and Multivessel Disease

Presenter: Henning Kelbæk, Renu Virmani

November 01, 2017

Presentation TCT 2017

State-of-the-Art Review: Intravascular Imaging and Physiology in ACS - Culprit Lesion and Vulnerable Plaque Assessment

Presenter: Henning Kelbæk, Renu Virmani, Francesco Prati

November 01, 2017

Presentation TCT 2017

Theoretical Beneficial Effects of Eliminating the Polymer From DES: From Mechanical Issues to Biocompatibility

Presenter: Mitchell W. Krucoff, Chaim S. Lotan, Renu Virmani

November 01, 2017

Presentation TCT 2017

TCT 571: Different Tissue Morphology of In-stent Restenosis in Hemodialysis Patient Compared With Non-hemodialysis Patients: A Prospective Multicenter Optical Coherence Tomography Registry

Presenter: Francesco Prati, Renu Virmani, Yoshinori Nagasawa, MD

October 31, 2017

Presentation TCT 2017

TCT 94: Safety and Efficacy of the Combo Bioegineered Stent in an All-Comer PCI Cohort - Results From the Mascot Postmarketing Registry

Presenter: Francesco Prati, Renu Virmani, Antonio Colombo

October 31, 2017

Presentation TCT 2017

TCT 93: Stent-Based Tissue Drug and Binding Target Protein Distributions - Durable vs Deployable Coatings

Presenter: Francesco Prati, Renu Virmani, Abraham Tzafriri, MD

October 31, 2017

Presentation TCT 2017

Pros and Cons of Bioabsorbable Polymer-Based DES: Will They Translate Into Improved Clinical Outcomes Compared to the Best Durable Polymer-Based DES?

Presenter: Ioannis Iakovou, Gert Richardt, Renu Virmani

October 30, 2017

Presentation TCT 2017

Are There Meaningful Differences Between Current Durable Polymer-Based vs Bioabsorbable Polymer-Based vs Polymer-Free Metallic DES? Pathologic Insights

Presenter: Giulio G. Stefanini, Stephan Windecker, Renu Virmani

October 30, 2017

Presentation TCT 2017

Origin of Thromboemboli in Atrial Fibrillation: Valvular vs Non-Valvular AF, Large vs Small Left Atria, and Other Considerations

Presenter: Christopher B. Granger, Horst Sievert, Renu Virmani

October 30, 2017

News Industry News

Protembis announces successful first-in-human use of its ProtEmbo® Cerebral Protection System in European trial

September 05, 2017

Presentation CCVVC 2016

Pathology of Drug Eluting Technologies: Are There Differences?

Presenter: Renu Virmani

June 15, 2016

Presentation CCVVC 2016

Calcium in the Peripheral and Coronary Arteries: The Pathologist View

Presenter: Renu Virmani

June 15, 2016

Advertisement

Case #6 (With Discussion): STEMI and an Intact Fibrous Cap

Case #5 (With Discussion): Spontaneous Coronary Artery Dissection

Case #4 (With Discussion): A Patient With STEMI and Multivessel Disease

State-of-the-Art Review: Intravascular Imaging and Physiology in ACS - Culprit Lesion and Vulnerable Plaque Assessment

Theoretical Beneficial Effects of Eliminating the Polymer From DES: From Mechanical Issues to Biocompatibility

TCT 571: Different Tissue Morphology of In-stent Restenosis in Hemodialysis Patient Compared With Non-hemodialysis Patients: A Prospective Multicenter Optical Coherence Tomography Registry

TCT 94: Safety and Efficacy of the Combo Bioegineered Stent in an All-Comer PCI Cohort - Results From the Mascot Postmarketing Registry

TCT 93: Stent-Based Tissue Drug and Binding Target Protein Distributions - Durable vs Deployable Coatings

Pros and Cons of Bioabsorbable Polymer-Based DES: Will They Translate Into Improved Clinical Outcomes Compared to the Best Durable Polymer-Based DES?

Are There Meaningful Differences Between Current Durable Polymer-Based vs Bioabsorbable Polymer-Based vs Polymer-Free Metallic DES? Pathologic Insights

Origin of Thromboemboli in Atrial Fibrillation: Valvular vs Non-Valvular AF, Large vs Small Left Atria, and Other Considerations

Protembis announces successful first-in-human use of its ProtEmbo® Cerebral Protection System in European trial

Pathology of Drug Eluting Technologies: Are There Differences?

Calcium in the Peripheral and Coronary Arteries: The Pathologist View

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content